Sign in or create an account to add this stock to your watchlist.
About Midatech Pharma (NASDAQ:MTP)
Midatech Pharma PLC, a specialty pharmaceutical company, focuses on the development and commercialization of oncology and other therapeutic products in the United Kingdom, Turkey, other European countries, and the United States. It offers Oravig, an orally dissolving buccal tablet for oral thrush and oropharyngeal candidiasis in adults; Gelclair, an oral rinse gel for the management and relief of pain arising from oral lesions of various etiologies; Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; and Soltamox, an oral liquid solution of tamoxifen citrate for the prevention of breast cancer. The company also engages in the marketing of Ferralet 90, a prescription iron supplement for the treatment of anemias that are responsive to oral iron therapy; and Aquoral, an artificial saliva spray to provide relief from chemotherapy/radiation therapy. In addition, it is involved in the research and development of various product candidates in the areas of oncology and neuroscience, including ophthalmology; and immunotherapy. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Trailing P/E Ratio-1.03
Forward P/E Ratio-2.09
Sales & Book Value
Annual Sales$9.79 million
Price / Sales2.35
Price / CashN/A
Book Value$1.46 per share
Price / Book0.52
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Midatech Pharma (NASDAQ:MTP) Frequently Asked Questions
What is Midatech Pharma's stock symbol?
Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP."
When is Midatech Pharma's next earnings date?
Who are some of Midatech Pharma's key competitors?
Some companies that are related to Midatech Pharma include Gemphire Therapeutics (GEMP), Axsome Therapeutics (AXSM), OncoSec Medical (ONCS), Sesen Bio (SESN), Sunesis Pharmaceuticals (SNSS), Medicure Inc. Common Stock (MCUJF), SCYNEXIS (SCYX), Cardiome Pharma (CRME), Trillium Therapeutics (TRIL), Eyenovia (EYEN), KaloBios (HGEN), Pharmaxis (PXSLY), Xenon Pharmaceuticals (XENE), Novan (NOVN) and Regulus Therapeutics (RGLS).
Who are Midatech Pharma's key executives?
Midatech Pharma's management team includes the folowing people:
- Dr. James Neil Phillips, Chief Exec. Officer & Director (Age 56)
- Mr. Nicholas John Robbins-Cherry, CFO, Company Sec. & Director (Age 49)
- Dr. Craig Cook, Chief Operating Officer (Age 51)
- Dr. Dan Palmer Ph.D., MBA, Chief Scientific Officer
- Mr. Rob Rainey FCA MBA MA, Head of Corp. Devel.
Has Midatech Pharma been receiving favorable news coverage?
News stories about MTP stock have trended somewhat positive this week, Accern reports. The research firm rates the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Midatech Pharma earned a media sentiment score of 0.08 on Accern's scale. They also assigned media coverage about the company an impact score of 46.31 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Midatech Pharma?
Shares of MTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Midatech Pharma's stock price today?
One share of MTP stock can currently be purchased for approximately $0.7538.
How big of a company is Midatech Pharma?
Midatech Pharma has a market capitalization of $23.02 million and generates $9.79 million in revenue each year. The company earns $-20,700,000.00 in net income (profit) each year or ($0.73) on an earnings per share basis. Midatech Pharma employs 79 workers across the globe.
How can I contact Midatech Pharma?
Midatech Pharma's mailing address is 65 INNOVATION DRIVE MILTON PARK, ABINGDON X0, OX14 4RQ. The company can be reached via phone at 44-0-12-3588-8300 or via email at [email protected]
MarketBeat Community Rating for Midatech Pharma (MTP)MarketBeat's community ratings are surveys of what our community members think about Midatech Pharma and other stocks. Vote "Outperform" if you believe MTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
Midatech Pharma (NASDAQ:MTP) Analyst Ratings History
(Data available from 5/27/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Midatech Pharma (NASDAQ:MTP) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Midatech Pharma (NASDAQ MTP) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 0.32%
Midatech Pharma (NASDAQ MTP) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
Midatech Pharma (NASDAQ MTP) News Headlines
Midatech Pharma (NASDAQ:MTP) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Midatech Pharma (NASDAQ:MTP) Income Statement, Balance Sheet and Cash Flow Statement
Midatech Pharma (NASDAQ MTP) Stock Chart for Sunday, May, 27, 2018